The purpose of this project is to identify the determinants of type 2 diabetes, obesity, and other chronic diseases in the Pima Indians, and elucidate their natural history. Genetic and environmental risk factors for type 2 diabetes have been studied. The residents of the study area, approximately 5000 people, have participated in a longitudinal population study since 1965, allowing observations of the natural history of diabetes mellitus. Risk factors for obesity, hypertension, and nephropathy are also studied, along with the relationships of these diseases to diabetes and their effects on mortality rates. The genetics of diabetes is studied by means of family studies and relationships of genetic markers to disease. The roles of obesity, serum insulin concentrations, impaired glucose regulation, occupational and leisure-time physical activity and diabetes in relatives are assessed. Studies of the genetics of type 2 diabetes and obesity are described in project report # Z01 DK 69028 PECR. Behavioral risk factors contribute to the incidence of type 2 diabetes in this population; both a self-identification of Anglo (as opposed to Indian) dietary preference and self-reported physical inactivity predict diabetes. It was determined that Pima Indian children become overweight, relative to national standards, even before the age of 5 years. Low serum levels of adiponectin predicted diabetes, suggesting that this recently-discovered hormone produced in fat cells may mediate the effect of adiposity on the development of type 2 diabetes. A longitudinal analysis of serum rheumatoid factor indicated a decline during the last three decades that was primarily due to a cohort effect. This supports the hypothesis of early-life influences on rheumatoid arthritis.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK069000-37
Application #
6673877
Study Section
(PECR)
Project Start
Project End
Budget Start
Budget End
Support Year
37
Fiscal Year
2002
Total Cost
Indirect Cost
Name
U.S. National Inst Diabetes/Digst/Kidney
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Perreault, Leigh; Kahn, Steven E; Christophi, Costas A et al. (2009) Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program. Diabetes Care 32:1583-8
International Expert Committee (2009) International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care 32:1327-34
Moore, Allan F; Jablonski, Kathleen A; McAteer, Jarred B et al. (2008) Extension of type 2 diabetes genome-wide association scan results in the diabetes prevention program. Diabetes 57:2503-10
Crandall, Jill P; Knowler, William C; Kahn, Steven E et al. (2008) The prevention of type 2 diabetes. Nat Clin Pract Endocrinol Metab 4:382-93
Rubin, Richard R; Ma, Yong; Marrero, David G et al. (2008) Elevated depression symptoms, antidepressant medicine use, and risk of developing diabetes during the diabetes prevention program. Diabetes Care 31:420-6
Sahota, Puneet K C; Knowler, William C; Looker, Helen C (2008) Depression, diabetes, and glycemic control in an American Indian community. J Clin Psychiatry 69:800-9
Florez, J C; Jablonski, K A; McAteer, J et al. (2008) Testing of diabetes-associated WFS1 polymorphisms in the Diabetes Prevention Program. Diabetologia 51:451-7
Mason, Clinton C; Hanson, Robert L; Knowler, William C (2007) Progression to type 2 diabetes characterized by moderate then rapid glucose increases. Diabetes 56:2054-61
Pavkov, Meda E; Hanson, Robert L; Knowler, William C et al. (2007) Changing patterns of type 2 diabetes incidence among Pima Indians. Diabetes Care 30:1758-63
Lachin, John M; Christophi, Costas A; Edelstein, Sharon L et al. (2007) Factors associated with diabetes onset during metformin versus placebo therapy in the diabetes prevention program. Diabetes 56:1153-9

Showing the most recent 10 out of 60 publications